Anbio Biotechnology (NNNN)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Anbio Biotechnology Stock (NNNN) Company Profile

Anbio Biotechnology

Healthcare (1118)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NNNN's Discussions on Twitter

Compare NNNN vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NNNN Anbio Biotechnology	20.50	989.31M	0	0	0	0.00
ISRG Intuitive Surgical Inc	471.70	170.20B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	161.05	45.41B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	77.17	38.26B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	231.92	33.86B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	41.00	33.33B	28.43B	1.16B	1.26B	1.4457

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Es liegen keine Finanzdaten für Anbio Biotechnology (NNNN) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Anbio Biotechnology (NNNN)

Anbio Biotechnology Stock (NNNN) Company Profile

Compare NNNN vs ISRG, BDX, ALC, RMD, MDLN

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World

Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today

Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World

TechTarget (TTGT) to Release Earnings on Wednesday - Defense World

Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha

NNNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head to Head Contrast - Defense World

NNNN Technical Analysis & Stock Price Forecast - Intellectia AI

NNNN Should I Buy - Intellectia AI

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility in the Medical Instruments Sector - DirectorsTalk Interviews

Critical Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology Outperforms Oncocyte in Head-to-Head Review - National Today

Celestica Inc. (TSE:CLS) Receives Average Recommendation of “Strong Buy” from Analysts - Defense World

Comparing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) - Defense World

Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Reviewing Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX) - Defense World

Diane Lazzaris Sells 2,747 Shares of WESCO International (NYSE:WCC) Stock - Defense World

Anbio Biotechnology and Oncocyte Compared: Which Stock Reigns Supreme? - National Today

Anbio Biotechnology (NNNN) Stock Analysis: What Investors Should Know About This German IVD Innovator - DirectorsTalk Interviews

Anbio Biotechnology prices $8M IPO at $5 per share - MSN

Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) Critical Comparison - Defense World

Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline - TipRanks

Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

IPO window reopens, med-tech class of 2025 gains 26% - bioworld.com

Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World

GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World

Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 8.4%Should You Buy? - MarketBeat

Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology and Oncocyte: A Financial Review - National Today

Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Why Anbio Biotechnology Class A Shares Took Off - TipRanks

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Anbio Biotechnology Class A Shares Surge After Volatility Pause - TipRanks

Disney, Micron Tech among market cap stock movers on Monday - Investing.com

Why Anbio Biotechnology Class A Shares Are Surging - TipRanks

InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa

Anbio Biotechnology (NNNN) Stock Trends and Sentiment 2026 - MarketBeat

Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria

Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks

Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com

Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year With Growth Potential - DirectorsTalk Interviews

NNNN Forecast — Price Prediction for 2026. Should I Buy NNNN? - Intellectia AI

Industries Limited Rebound Backed by Sentiment ShiftMACD Trading Signals & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NNNN